AAV9 administered systemically after reperfusion preferentially targets cardiomyocytes in the infarct border zone with pharmacodynamics suitable for the attenuation of left ventricular remodeling

OBJECTIVE: Adeno-associated virus serotype 9 (AAV9) vectors provide efficient and uniform gene expression to normal myocardium following systemic administration with kinetics that approach steady state within 2–3 weeks. However, due to the delayed onset of gene expression, AAV vectors have not previ...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Konkalmatt, Prasad R., Wang, Feng, Piras, Bryan A., Xu, Yaqin, O’Connor, Daniel M., Beyers, Ronald J., Epstein, Frederick H., Annex, Brian H., Hossack, John A., French, Brent A.
Formato: Artigo
Idioma:Inglês
Publicado em: 2012
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3729029/
https://ncbi.nlm.nih.gov/pubmed/23065925
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/jgm.2673
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados